头颈部血管异常的医疗管理和治疗进展:第2部分。

IF 1.3 4区医学 Q3 DENTISTRY, ORAL SURGERY & MEDICINE

Oral and Maxillofacial Surgery Clinics of North America Pub Date : 2023-11-17 DOI:10.1016/j.coms.2023.09.012

Jorie Gatts MD , Srinivasa R. Chandra BDS, MD, FDS, FIBCSOMS , Kiersten Ricci MD

引用次数: 0

摘要

遗传和体细胞基因突变的发现，以及临床和科学研究的进步，提高了对血管异常的理解，改变了治疗模式。为了最大限度地减少对侵入性手术的需求并改善疾病的预后，分子靶向药物和抗血管生成药物已经成为手术的辅助手段，并且越来越多地成为血管异常的主要治疗方法。本文重点介绍了非恶性血管肿瘤和血管畸形的常用和新兴治疗药物，以及相关血液异常的医学管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Medical Management and Therapeutic Updates on Vascular Anomalies of the Head and Neck

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Oral and Maxillofacial Surgery Clinics of North America DENTISTRY, ORAL SURGERY & MEDICINE-

CiteScore

3.20

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Published four times a year—February, May, August, and November—Oral and Maxillofacial Surgery Clinics of North America updates you on the latest trends in patient management and the newest advances, as well as provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in oral and maxillofacial surgery. Topics include reconstructive surgery, implants, dentoalveolar surgery, cleft and craniofacial surgery, craniomaxillofacial trauma surgery, TMJ, and cosmetic surgery.